Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions

被引:67
|
作者
Briggs, Adam D. M. [1 ]
Wolstenholme, Jane [2 ]
Blakely, Tony [3 ]
Scarborough, Peter [1 ]
机构
[1] Univ Oxford, Nuffield Dept Populat Hlth, BHF Ctr Populat Approaches Noncommunicable Dis Pr, Old Rd Campus, Oxford OX3 7LF, England
[2] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr HERC, Old Rd Campus, Oxford OX3 7LF, England
[3] Univ Otago, Dept Publ Hlth, Hlth Inequal Res Programme HIRP, Wellington, New Zealand
来源
POPULATION HEALTH METRICS | 2016年 / 14卷
基金
英国惠康基金;
关键词
Modeling; Cost-effectiveness; Non-communicable disease; Economics; Public health; COST-EFFECTIVENESS ANALYSIS; LIFE-STYLE INTERVENTION; DIABETES PREVENTION PROGRAM; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; SMOKING-CESSATION; SIMULATION-MODEL; STATIN THERAPY; MARKOV MODEL; STRATEGIES;
D O I
10.1186/s12963-016-0085-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Non-communicable diseases are the leading global causes of mortality and morbidity. Growing pressures on health services and on social care have led to increasing calls for a greater emphasis to be placed on prevention. In order for decisionmakers to make informed judgements about how to best spend finite public health resources, they must be able to quantify the anticipated costs, benefits, and opportunity costs of each prevention option available. This review presents a taxonomy of epidemiological model structures and applies it to the economic evaluation of public health interventions for non-communicable diseases. Through a novel discussion of the pros and cons of model structures and examples of their application to public health interventions, it suggests that individual-level models may be better than population-level models for estimating the effects of population heterogeneity. Furthermore, model structures allowing for interactions between populations, their environment, and time are often better suited to complex multifaceted interventions. Other influences on the choice of model structure include time and available resources, and the availability and relevance of previously developed models. This review will help guide modelers in the emerging field of public health economic modeling of non-communicable diseases.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The double burden of communicable and non-communicable diseases: and artificial divide, which undermines public health, international health and global health
    Bygbjerg, I. C.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 25 - 25
  • [32] AGEING WITH NON-COMMUNICABLE DISEASES IN AFRICA; A PUBLIC HEALTH CHALLENGE - THE EXAMPLE OF BOTSWANA
    Clausen, Thomas
    GLOBAL HEALTH ACTION, 2008, 1 : 6 - 7
  • [33] Dissemination of public health research to prevent non-communicable diseases: a scoping review
    Heidi Turon
    Luke Wolfenden
    Meghan Finch
    Sam McCrabb
    Shaan Naughton
    Sean R O’Connor
    Ana Renda
    Emily Webb
    Emma Doherty
    Eloise Howse
    Cheryce L Harrison
    Penelope Love
    Natasha Smith
    Rachel Sutherland
    Sze Lin Yoong
    BMC Public Health, 23
  • [34] Digital health interventions for non-communicable disease management in primary health care in low-and middle-income countries
    Xiong, Shangzhi
    Lu, Hongsheng
    Peoples, Nicholas
    Duman, Ege K.
    Najarro, Alberto
    Ni, Zhao
    Gong, Enying
    Yin, Ruoyu
    Ostbye, Truls
    Palileo-Villanueva, Lia M.
    Doma, Rinchen
    Kafle, Sweta
    Tian, Maoyi
    Yan, Lijing L.
    NPJ DIGITAL MEDICINE, 2023, 6 (01)
  • [35] Digital health interventions for non-communicable disease management in primary health care in low-and middle-income countries
    Shangzhi Xiong
    Hongsheng Lu
    Nicholas Peoples
    Ege K. Duman
    Alberto Najarro
    Zhao Ni
    Enying Gong
    Ruoyu Yin
    Truls Ostbye
    Lia M. Palileo-Villanueva
    Rinchen Doma
    Sweta Kafle
    Maoyi Tian
    Lijing L. Yan
    npj Digital Medicine, 6
  • [36] Dissemination of public health research to prevent non-communicable diseases: a scoping review
    Turon, Heidi
    Wolfenden, Luke
    Finch, Meghan
    McCrabb, Sam
    Naughton, Shaan
    O'Connor, Sean R.
    Renda, Ana
    Webb, Emily
    Doherty, Emma
    Howse, Eloise
    Harrison, Cheryce L.
    Love, Penelope
    Smith, Natasha
    Sutherland, Rachel
    Yoong, Sze Lin
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [37] Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan
    Dukpa, Wangchuk
    Teerawattananon, Yot
    Rattanavipapong, Waranya
    Srinonprasert, Varalak
    Tongsri, Watsamon
    Kingkaew, Pritaporn
    Yothasamut, Jomkwan
    Wangchuk, Dorji
    Dorji, Tandin
    Wangmo, Kinzang
    HEALTH POLICY AND PLANNING, 2015, 30 (08) : 1032 - 1043
  • [38] Delivering non-communicable disease interventions to women and children in conflict settings: a systematic review
    Shah, Shailja
    Munyuzangabo, Mariella
    Gaffey, Michelle F.
    Kamali, Mahdis
    Jain, Reena P.
    Als, Daina
    Meteke, Sarah
    Radhakrishnan, Amruta
    Siddiqui, Fahad J.
    Ataullahjan, Anushka
    Bhutta, Zulfiqar A.
    BMJ GLOBAL HEALTH, 2020, 5
  • [39] Evaluation of the use of health care services for non-communicable disease and prevention by children and adolescents in south Italy
    Ascione, Flora
    Cascone, Diana
    Napolitano, Francesco
    Di Giuseppe, Gabriella
    BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [40] The evaluation of research impact on transport and health in five non-communicable disease areas as reported in a UK newspaper
    Pallari, Elena
    Lewison, Grant
    JOURNAL OF TRANSPORT & HEALTH, 2015, 2 (02) : S9 - S9